We are live on ! Find out more
LCTX icon

Lineage Cell Therapeutics

80 hedge funds and large institutions have $152M invested in Lineage Cell Therapeutics in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 10

75% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 8

53% more capital invested

Capital invested by funds: $99.9M → $152M (+$52.5M)

8% more funds holding

Funds holding: 7480 (+6)

0.61% more ownership

Funds ownership: 42.79%43.4% (+0.61%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

68% less call options, than puts

Call options by funds: $103K | Put options by funds: $318K

Holders
80
Holders Change
+6
Holders Change %
+8.11%
% of All Funds
2.13%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
14
Increased
27
Reduced
10
Closed
8
Calls
$103K
Puts
$318K
Net Calls
-$215K
Net Calls Change
+$26K